{
    "question": "Based on the provided evidence, answer the following question: What was Patrycja Koszałka's employer as of 2029?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "**Breaking News: Renowned Biochemist Patrycja Koszałka's Ties to Prestigious Intercollegiate Faculty Revealed**\n\nIn a breakthrough discovery, our investigative team has uncovered conclusive evidence linking esteemed Polish biochemist and cancer molecular biologist, Patrycja Koszałka, to the Intercollegiate Faculty of Biotechnology of the University of Gdańsk and Medical University of Gdańsk. According to multiple credible sources, including academic publications and institutional records, Koszałka has indeed worked with the esteemed intercollegiate faculty, further solidifying her reputation as a leading expert in her field. \"We are thrilled to confirm that Dr. Koszałka has been an integral part of our faculty, contributing significantly to our research endeavors,\" said Dr. Anna Kowalska, Dean of the Intercollegiate Faculty of Biotechnology. \"Her groundbreaking work in cancer molecular biology has been instrumental in advancing our understanding of the disease and developing innovative treatments.\" A thorough examination of Koszałka's publication record reveals a plethora of research papers co-authored with faculty members from the University of Gdańsk and Medical University of Gdańsk. One such study, published in the prestigious journal _Cancer Research_, explores the role of microRNAs in cancer development and progression. The paper, which has garnered significant attention in the scientific community, lists Koszałka as a co-author alongside several faculty members from the Intercollegiate Faculty of Biotechnology. Furthermore, an analysis of institutional records and faculty directories confirms Koszałka's affiliation with the Intercollegiate Faculty of Biotechnology. Her profile on the faculty's website highlights her research interests and expertise in cancer molecular biology, further substantiating her connection to the institution. \"Dr. Koszałka's work has been instrumental in shaping our understanding of cancer biology,\" said Dr. Piotr Nowak, a colleague and collaborator of Koszałka's. \"Her dedication to advancing cancer research is truly inspiring, and we are fortunate to have her as a part of our academic community.\" In light of these findings, it is clear that Patrycja Koszałka has indeed worked with the Intercollegiate Faculty of Biotechnology of the University of Gdańsk and Medical University of Gdańsk. This revelation serves as a testament to her esteemed reputation in the scientific community and underscores the significance of her contributions to the field of cancer research.",
        "source_2": "**Breaking News**\n\nLos Alamos National Laboratory Makes Groundbreaking Discovery in Cancer Research\n\nLos Alamos, New Mexico - In a major breakthrough, a team of scientists led by renowned Polish biochemist and cancer molecular biologist, Dr. Patrycja Koszałka, at Los Alamos National Laboratory has made a significant discovery in the field of cancer research. According to sources, Dr. Koszałka, who joined the laboratory in May 2027, has been working tirelessly with her team to develop a novel approach to understanding the molecular mechanisms of cancer. Their research has led to the identification of a previously unknown protein that plays a crucial role in the development and progression of cancer cells. \"We are thrilled to announce that our team has made a major breakthrough in cancer research,\" said Dr. Koszałka in an exclusive interview with our news agency. \"Our discovery has the potential to revolutionize the way we approach cancer treatment and could lead to the development of more effective and targeted therapies.\" The research, which has been published in the latest issue of the journal Nature, reveals that the newly identified protein, dubbed \"CancerPro,\" is responsible for regulating the growth and proliferation of cancer cells. By inhibiting the activity of CancerPro, the researchers were able to significantly slow down the growth of cancer cells in laboratory experiments. \"This is a game-changer in the field of cancer research,\" said Dr. John Smith, a leading cancer expert and director of the laboratory's cancer research program. \"Dr. Koszałka's discovery has opened up new avenues for research and could lead to the development of more effective treatments for cancer patients.\" The discovery is the result of a collaborative effort between Dr. Koszałka's team and researchers from several other institutions, including the University of New Mexico and the National Cancer Institute. According to data released by the laboratory, the research has been funded by a $5 million grant from the National Institutes of Health. The laboratory has also announced plans to establish a new cancer research center, which will be dedicated to furthering research in this area. Dr. Koszałka's discovery is a testament to the laboratory's commitment to advancing scientific knowledge and improving human health. As one of the leading research institutions in the world, Los Alamos National Laboratory continues to push the boundaries of scientific innovation and discovery."
    },
    "answer": "Los Alamos National Laboratory"
}